Rallybio Corp Stock Performance
| RLYB Stock | USD 1.10 0.02 1.85% |
The company holds a Beta of 0.5, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Rallybio Corp's returns are expected to increase less than the market. However, during the bear market, the loss of holding Rallybio Corp is expected to be smaller as well. Rallybio Corp right now holds a risk of 2.34%. Please check Rallybio Corp total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Rallybio Corp will be following its historical price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Rallybio Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Rallybio Corp is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more
1 | Rallybio to Present Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations at the American Society of H... | 09/23/2024 |
2 | Acquisition by Hunt Ronald of 16500 shares of Rallybio Corp at 1.91 subject to Rule 16b-3 | 10/16/2024 |
3 | Rallybio Co. Receives 10.00 Average Price Target from Brokerages | 10/21/2024 |
4 | Acquisition by Nash Christine A of 15490 shares of Rallybio Corp at 5.64 subject to Rule 16b-3 | 11/20/2024 |
5 | Rallybio to Provide Update on RLYB116 Program, an Innovative Subcutaneously Injected C5 Inhibitor | 11/25/2024 |
6 | Rallybio Announces Publication of Target-Mediated Drug Disposition Modeling and Simulations Informing the RLYB212 Dosing Regimen in Pregnant Women | 11/27/2024 |
| Begin Period Cash Flow | 57 M |
Rallybio |
Rallybio Corp Relative Risk vs. Return Landscape
If you would invest 110.00 in Rallybio Corp on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Rallybio Corp or generate 0.0% return on investment over 90 days. Rallybio Corp is currently generating 0.027% in daily expected returns and assumes 2.3407% risk (volatility on return distribution) over the 90 days horizon. In different words, 20% of stocks are less volatile than Rallybio, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Rallybio Corp Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Rallybio Corp's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Rallybio Corp, and traders can use it to determine the average amount a Rallybio Corp's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0115
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RLYB |
Estimated Market Risk
| 2.34 actual daily | 20 80% of assets are more volatile |
Expected Return
| 0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Rallybio Corp is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rallybio Corp by adding Rallybio Corp to a well-diversified portfolio.
Rallybio Corp Fundamentals Growth
Rallybio Stock prices reflect investors' perceptions of the future prospects and financial health of Rallybio Corp, and Rallybio Corp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Rallybio Stock performance.
| Return On Equity | -0.67 | ||||
| Return On Asset | -0.39 | ||||
| Operating Margin | (40.35) % | ||||
| Current Valuation | (29.27 M) | ||||
| Shares Outstanding | 41.49 M | ||||
| Price To Book | 0.64 X | ||||
| Price To Sales | 76.31 X | ||||
| EBITDA | (72.37 M) | ||||
| Net Income | (74.56 M) | ||||
| Cash And Equivalents | 147.37 M | ||||
| Cash Per Share | 4.59 X | ||||
| Total Debt | 392 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 21.20 X | ||||
| Book Value Per Share | 1.93 X | ||||
| Cash Flow From Operations | (60.27 M) | ||||
| Earnings Per Share | (1.57) X | ||||
| Market Capitalization | 45.64 M | ||||
| Total Asset | 115.62 M | ||||
| Retained Earnings | (235.25 M) | ||||
| Working Capital | 105.53 M | ||||
About Rallybio Corp Performance
By analyzing Rallybio Corp's fundamental ratios, stakeholders can gain valuable insights into Rallybio Corp's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Rallybio Corp has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Rallybio Corp has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.64) | (0.68) | |
| Return On Capital Employed | (0.74) | (0.78) | |
| Return On Assets | (0.64) | (0.68) | |
| Return On Equity | (0.70) | (0.67) |
Things to note about Rallybio Corp performance evaluation
Checking the ongoing alerts about Rallybio Corp for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Rallybio Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Rallybio Corp may become a speculative penny stock | |
| Net Loss for the year was (74.56 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Rallybio Corp currently holds about 147.37 M in cash with (60.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.59, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Rallybio Corp has a poor financial position based on the latest SEC disclosures | |
| Over 76.0% of the company shares are owned by institutional investors | |
| Latest headline from businesswire.com: Rallybio Announces Publication of Target-Mediated Drug Disposition Modeling and Simulations Informing the RLYB212 Dosing Regimen in Pregnant Women |
- Analyzing Rallybio Corp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Rallybio Corp's stock is overvalued or undervalued compared to its peers.
- Examining Rallybio Corp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Rallybio Corp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Rallybio Corp's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Rallybio Corp's stock. These opinions can provide insight into Rallybio Corp's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Rallybio Stock analysis
When running Rallybio Corp's price analysis, check to measure Rallybio Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rallybio Corp is operating at the current time. Most of Rallybio Corp's value examination focuses on studying past and present price action to predict the probability of Rallybio Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rallybio Corp's price. Additionally, you may evaluate how the addition of Rallybio Corp to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |